HeraMED Limited (HMD.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.039 (-2.50%) as of
Key statistics
- Market cap
- 45.19M
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0300 – 0.0550
- Beta
- 0.01
- Revenue (TTM)
- 330.44k
- Profit margin
- 0.00%
- Analyst target
- A$0.11
- Volume
- 597.46k
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hawthorn East, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.